↓ Skip to main content

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Overview of attention for article published in Frontiers in immunology, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
10 X users
reddit
4 Redditors

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
Published in
Frontiers in immunology, January 2022
DOI 10.3389/fimmu.2021.816515
Pubmed ID
Authors

Hager Mohamed, Theodore Gurrola, Rachel Berman, Mackenzie Collins, Ilker K. Sariyer, Michael R. Nonnemacher, Brian Wigdahl

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 14%
Student > Master 6 6%
Student > Ph. D. Student 6 6%
Other 4 4%
Professor 3 3%
Other 6 6%
Unknown 56 60%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 13%
Immunology and Microbiology 7 7%
Medicine and Dentistry 6 6%
Agricultural and Biological Sciences 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 8 9%
Unknown 54 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2023.
All research outputs
#2,419,996
of 25,392,582 outputs
Outputs from Frontiers in immunology
#2,375
of 31,549 outputs
Outputs of similar age
#58,858
of 515,638 outputs
Outputs of similar age from Frontiers in immunology
#113
of 1,553 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 1,553 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.